cagrilintide protocol Weight Loss Results: What Patients in Louisiana Need to Know Efficacy and Safety of Cagrilintide

Protocol Used: 0.25 mg BPC-157 subcutaneous injection daily for 6 weeks, administered 2 inches proximal to Achilles insertion point, combined with eccentric heel drops and gradual return to running

Its full name, "Body Protection Compound," hints at its origins as a protective substance in the digestive system

It acts as an amylin receptor agonist, activating AMY1, AMY2, and AMY3 receptors heterodimers of the calcitonin receptor with receptor activity-modifying proteins (RAMPs) to produce satiety signaling, gastric emptying inhibition, and glucagon suppression

Why isnt it approved yet

Published 2018 Jul 7

The elimination half-life sits under 30 minutes, meaning the intact peptide clears from the body relatively quickly